Literature DB >> 8433082

The acute-phase response and associated lipoprotein abnormalities accompanying lymphoma.

J D Blackman1, V G Cabana, T Mazzone.   

Abstract

Lipoprotein abnormalities seen in patients with inflammatory diseases are thought to develop secondary to circulating cytokines and the accompanying acute-phase response. Patient's with lymphoma may develop similar lipoprotein abnormalities but the mechanism is unclear. We report a patient with B-cell lymphoma who presented with an HDL cholesterol level of 3 mg dl-1, an ApoA level of 17.4 mg dl-1, elevated triglyceride level (272 mg dl-1) and an elevated ApoB level of 156 mg dl-1. Density gradient analysis of the patient's lipoproteins demonstrated a virtual absence of an identifiable HDL particle. Serum amyloid A and C-reactive protein were also elevated. All of the lipoprotein abnormalities resolved with chemotherapy and resolution of the acute-phase response. The acute-phase response may be associated with striking lipoprotein abnormalities in a subset of patients with lymphoma. Lymphoma should be included in the differential diagnosis of patients with hypertriglyceridaemia and low HDL cholesterol.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8433082     DOI: 10.1111/j.1365-2796.1993.tb00674.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  11 in total

1.  Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma.

Authors:  Liang Wang; Pei-dong Chi; Hao Chen; Jin Xiang; Zhong-jun Xia; Yu-jing Zhang
Journal:  Tumour Biol       Date:  2014-03

2.  Severe lactic acidosis, hypertriglyceridemia, and extensive axial skeleton involvement in a case of disseminated Burkitt's lymphoma.

Authors:  Ketan Kulkarni; Satvinder Kaur; Anupam Sibal; Nameet Jerath; Laxman S Arya
Journal:  Int J Hematol       Date:  2010-03-09       Impact factor: 2.490

3.  NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

Authors:  J C Pickup; M B Mattock; G D Chusney; D Burt
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

4.  Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency.

Authors:  Andreas G Moraitis; Lita A Freeman; Robert D Shamburek; Robert Wesley; Wyndham Wilson; Cliona M Grant; Susan Price; Stephen Demosky; Seth G Thacker; Abdalrahman Zarzour; Ronald L Hornung; Frank Pucino; Gyorgy Csako; Cheryl Yarboro; Iain B McInnes; Takashi Kuroiwa; Dimitrios Boumpas; V Koneti Rao; Gabor G Illei; Alan T Remaley
Journal:  J Clin Lipidol       Date:  2014-10-05       Impact factor: 4.766

5.  A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.

Authors:  Unhee Lim; D Michal Freedman; Bruce W Hollis; Ronald L Horst; Mark P Purdue; Nilanjan Chatterjee; Stephanie J Weinstein; Lindsay M Morton; Arthur Schatzkin; Jarmo Virtamo; Martha S Linet; Patricia Hartge; Demetrius Albanes
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

6.  Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis.

Authors:  Sharon Hensley Alford; George Divine; Chun Chao; Laurel A Habel; Nalini Janakiraman; Yun Wang; Heather Spencer Feigelson; Delia Scholes; Doug Roblin; Mara M Epstein; Lawrence Engel; Suzanne Havstad; Karen Wells; Marianne Ulcickas Yood; Joan Fortuny; Christine Cole Johnson
Journal:  Cancer Causes Control       Date:  2017-11-30       Impact factor: 2.506

7.  The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.

Authors:  Donovan McGrowder; Cliff Riley; Errol Y St A Morrison; Lorenzo Gordon
Journal:  Cholesterol       Date:  2010-12-23

8.  Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy.

Authors:  Xin Li; Zi-Li Liu; Yu-Tuan Wu; He Wu; Wei Dai; Bilal Arshad; Zhou Xu; Hao Li; Kai-Nan Wu; Ling-Quan Kong
Journal:  Lipids Health Dis       Date:  2018-04-20       Impact factor: 3.876

9.  Transient hypertriglyceridemia: a common finding during Epstein-Barr virus-induced infectious mononucleosis.

Authors:  Emilio-Manuel Páez-Guillán; Joaquín Campos-Franco; Rosario Alende; Yago Garitaonaindía; Arturo González-Quintela
Journal:  Lipids Health Dis       Date:  2021-12-12       Impact factor: 3.876

10.  Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma.

Authors:  Ombretta Repetto; Valli De Re; Lara Mussolin; Massimo Tedeschi; Caterina Elia; Maurizio Bianchi; Salvatore Buffardi; Alessandra Sala; Roberta Burnelli; Maurizio Mascarin
Journal:  Int J Mol Sci       Date:  2020-03-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.